Literature DB >> 11294678

Tissue cytokine responses in canine visceral leishmaniasis.

R J Quinnell1, O Courtenay, M A Shaw, M J Day, L M Garcez, C Dye, P M Kaye.   

Abstract

To elucidate the local tissue cytokine response of dogs infected with Leishmania chagasi, cytokine mRNA levels were measured in bone marrow aspirates from 27 naturally infected dogs from Brazil and were compared with those from 5 uninfected control animals. Interferon-gamma mRNA accumulation was enhanced in infected dogs and was positively correlated with humoral (IgG1) but not with lymphoproliferative responses to Leishmania antigen in infected dogs. Increased accumulation of mRNA for interleukin (IL)-4, IL-10, and IL-18 was not observed in infected dogs, and mRNA for these cytokines did not correlate with antibody or proliferative responses. However, infected dogs with detectable IL-4 mRNA had significantly more severe symptoms. IL-13 mRNA was not detectable in either control or infected dogs. These data suggest that clinical symptoms are not due to a deficiency in interferon-gamma production. However, in contrast to its role in human visceral leishmaniasis, IL-10 may not play a key immunosuppressive role in dogs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294678     DOI: 10.1086/319869

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.

Authors:  E Carrillo; S Ahmed; K Goldsmith-Pestana; J Nieto; Y Osorio; B Travi; J Moreno; D McMahon-Pratt
Journal:  Vaccine       Date:  2006-11-10       Impact factor: 3.641

Review 2.  Advances toward Diagnostic Tools for Managing Zoonotic Visceral Leishmaniasis.

Authors:  Malcolm S Duthie; Aurore Lison; Orin Courtenay
Journal:  Trends Parasitol       Date:  2018-08-18

3.  In situ CUTANEOUS CELLULAR IMMUNE RESPONSE IN DOGS NATURALLY AFFECTED BY VISCERAL LEISHMANIASIS.

Authors:  Claudio Nazaretian Rossi; Thaise Yumie Tomokane; Luis Fábio da Silva Batista; Mary Marcondes; Carlos Eduardo Larsson; Márcia Dalastra Laurenti
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-07-11       Impact factor: 1.846

4.  Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis.

Authors:  Blaise Dondji; Eva Pérez-Jimenez; Karen Goldsmith-Pestana; Mariano Esteban; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Evaluation of TNF-α, IL-4, and IL-10 and parasite density in spleen and liver of L. (L.) chagasi naturally infected dogs.

Authors:  A DE F Michelin; S H V Perri; V M F De Lima
Journal:  Ann Trop Med Parasitol       Date:  2011-07

6.  Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.

Authors:  Henry W Murray; Christina M Lu; Smita Mauze; Sherry Freeman; Andre L Moreira; Gilla Kaplan; Robert L Coffman
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

7.  Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs.

Authors:  Yasuyuki Goto; Randall F Howard; Ajay Bhatia; Joelma Trigo; Maria Nakatani; Eduardo M Netto; Steven G Reed
Journal:  Vet Parasitol       Date:  2008-11-05       Impact factor: 2.738

8.  Hepatic extracellular matrix alterations in dogs naturally infected with Leishmania (Leishmania) chagasi.

Authors:  Ferdinan Almeida Melo; Eliane Perlatto Moura; Raul Rio Ribeiro; Cíntia Fontes Alves; Marcelo Vidigal Caliari; Washington Luiz Tafuri; Kátia da Silva Calabrese; Wagner Luiz Tafuri
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

9.  Canis familiaris telomerase reverse transcriptase undergoes alternative splicing.

Authors:  Katerina Angelopoulou; Michael Zavlaris; Nikolaos Papaioannou; Ioannis Vlemmas
Journal:  Mamm Genome       Date:  2008-10-04       Impact factor: 2.957

10.  Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.

Authors:  V Corpas-López; G Merino-Espinosa; C Acedo-Sánchez; V Díaz-Sáez; M C Navarro-Moll; F Morillas-Márquez; J Martín-Sánchez
Journal:  Vet Res Commun       Date:  2018-02-16       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.